In addition, a study involving CRC patients showed that exosomal HOTAIR is positively correlated with infiltration of PDL1+ B cells in tumor tissues, suggesting that exosomal therapy targeting HOTAIR may be a new therapeutic strategy for CRC. The gene discussed is HOTAIR; the disease is colorectal carcinoma.